Saturday, 31 October 2026European Markets

GEOJUNXION Stock Bullish By 17% In The Last 5 Sessions

Loading stream...

Financial literacy is of utmost importance in today's volatile stock market. One company that stands out is GeoJunxion (AEX-Index: GOJXN.AS), a producer of digital maps and premium location content on a global scale. GeoJunxion has experienced quite a notable rise in recent times.

Performance of GeoJunxion

GeoJunxion has shown an astounding 17.65% surge since last Friday, a figure that's quite striking when measured against its respective AEX-Index which recorded a decline of 2.54% reaching EUR737.63 as reported on Friday. However, GeoJunxion recently had a closing price of EUR1.00, which represents a substantial 52.38% drop from its 52-week high of EUR2.10. Despite this, the data suggests the potential for growth and recovery, particularly as GeoJunxion had trailing twelve-month earnings per share of -0.2 with 2.12% return on equity.

GeoJunxion's Market Indicators

It appears that GeoJunxion's stock might be oversold as suggested by its stochastic oscillator and could see an immediate rebound. Investors, however, need to be cautious. The company's volatility metrics display mixed patterns - it recorded an average positive intraday variation of 3.29% last week that contradicts its negative 0.34% monthly volatility metrics but seems to have rebounded to positive 3.22% quarterly variations.

GeoJunxion's Revenue Growth and Trading Volume

GeoJunxion reported quite an impressive year-over-year quarterly revenue increase of 31.3% and now stands at an impressive annual total of 1.1M for its trailing 12 months. Additionally, its recent trading volume of 9207 remarkably outpaces its average trading volume of 2352, showing a heightened degree of investor enthusiasm.

Understanding GeoJunxion's Indicators and Fundamentals

Having a clear understanding of these indicators and the company's fundamentals can equip investors with the information necessary to make sound financial decisions in the world of stock markets. GeoJunxion is a standout in this regard, with its potential for growth and robust performance metrics that designate it as one of the must-watch companies in today's financial landscape.

More news about GEOJUNXION (GOJXN.AS).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com